Androderm
Please select a testosterone article from the list below:
- Business Wire - Enzo Biochem Appoints Gary C. Cupit, Former Novartis Pharmaceutical Executive, President of Enzo Therapeutics Unit
- Airline Industry Information - Russian cyclist detained at Sydney Airport with anabolic steroids admits owning the drugs
- Airline Industry Information - Russian cycling coach and cyclist detained at Sydney Airport with anabolic steroids
- Business Wire - Paladin Labs and Hydro Med Sciences Sign License Agreement for a Once Yearly Implant for Prostate Cancer
- Business Wire - Pharmacia and Paladin Enter Into Distribution Agreement for Certain Endocrinology and Women's Health Brands
- Biotech Business - ANDROGEL TESTOSTERONE GEL IMPROVES SEX, MOOD, AND STRENGTH.
- Chain Drug Review - Watson rights
- Nursing - Drug quiz
- Medical Marketing and Media - Androderm leaflet attacked by FDA
- Business Wire - TheraTech Inc. Reports Continued Earnings Gains; Firm Posts 10th Successive Profitable Quarter
Monday 16th of October 2006
Business Wire - Enzo Biochem Appoints Gary C. Cupit, Former Novartis Pharmaceutical Executive, President of Enzo Therapeutics Unit
Monday 16th of October 2006, 12:00 amOctober 16, 2006 -- NEW YORK -- Enzo Biochem, Inc. (NYSE:ENZ) today announced the appointment of Gary C. Cupit, PharmD, to the newly created position of President of...
Wednesday 28th of May 2003
Airline Industry Information - Russian cyclist detained at Sydney Airport with anabolic steroids admits owning the drugs
Wednesday 28th of May 2003, 12:00 amMay 28, 2003 -- AIRLINE INDUSTRY INFORMATION-(C)1997-2003 M2 COMMUNICATIONS LTD A Russian cyclist has reportedly admitted to owning steroids discovered in her...
Monday 19th of May 2003
Airline Industry Information - Russian cycling coach and cyclist detained at Sydney Airport with anabolic steroids
Monday 19th of May 2003, 12:00 amMay 19, 2003 -- AIRLINE INDUSTRY INFORMATION-(C)1997-2003 M2 COMMUNICATIONS LTD A Russian cycling coach has pleaded guilty to importing anabolic steroids after...
Friday 4th of October 2002
Business Wire - Paladin Labs and Hydro Med Sciences Sign License Agreement for a Once Yearly Implant for Prostate Cancer
Friday 4th of October 2002, 12:00 amOctober 4, 2002 -- Business Editors & Health/Medical Writers BIOWIRE2K MONTREAL & CRANBURY, N.J.--(BUSINESS WIRE)--Oct. 4, 2002 Paladin Labs Inc....
Thursday 17th of January 2002
Business Wire - Pharmacia and Paladin Enter Into Distribution Agreement for Certain Endocrinology and Women's Health Brands
Thursday 17th of January 2002, 12:00 amJanuary 17, 2002 -- Business Editors & Health/Medical Writers BIOWIRE2K MONTREAL--(BW HealthWire)--Jan. 17, 2002 Pharmacia Canada Inc. (NYSE:PHA) and Paladin...
Tuesday 1st of August 2000
Biotech Business - ANDROGEL TESTOSTERONE GEL IMPROVES SEX, MOOD, AND STRENGTH.
Tuesday 1st of August 2000, 12:00 amAugust 1, 2000 -- Data presented recently shows that the new testosterone replacement therapy, testosterone gel, which is available commercially as AndroGel(R)...
Monday 28th of June 1999
Chain Drug Review - Watson rights
Monday 28th of June 1999, 12:00 amJune 28, 1999 -- Watson Pharmaceuticals Inc. has reacquired marketing rights for Thera Tech Inc.'s Androderm testosterone transdermal development system from...
Thursday 1st of April 1999
Nursing - Drug quiz
Thursday 1st of April 1999, 12:00 amApril 1, 1999 -- How well do you really know the drugs you administer-their indications, dosages, interactions, and possible adverse effects? Test yourself with...
Monday 1st of February 1999
Medical Marketing and Media - Androderm leaflet attacked by FDA
Monday 1st of February 1999, 12:00 amFebruary 1, 1999 -- A leaflet stating, "Patients prefer Androderm over Testoderm TTS" was misleading, charged the DDMAC's Mark Askine in a November 25 letter to...
Wednesday 21st of October 1998
Business Wire - TheraTech Inc. Reports Continued Earnings Gains; Firm Posts 10th Successive Profitable Quarter
Wednesday 21st of October 1998, 12:00 amOctober 21, 1998 -- SALT LAKE CITY--(BUSINESS WIRE)--Oct. 21, 1998--TheraTech Inc. (Nasdaq:THRT) Wednesday reported third quarter earnings of $2,421,000 or $0.11 per...